In the same CCA tumor xenografts (Supplementary Figure 6), both ICAM1 ADCs exhibited significantly higher potency against CCA tumors than their non-targeting counterparts, suggesting that ICAM1 ADCs can mediate their anti-tumor activity in a tumor-specific manner. This evidence concerns the gene ICAM1 and cholangiocarcinoma.